Environmental insults are a major detrimental impact to respiratory health. Therefore, chronic lung diseases are the research focus of the Institute of Lung Health and Immunity (LHI) and the Comprehensive Pneumology Center (CPC). We strive to elucidate the underlying mechanisms of diseases such as chronic obstructive pulmonary disease (COPD), lung fibrosis, lung cancer, asthma and complications following lung transplantation (bronchiolitis obliterans) and translate them into therapeutic approaches for patients. We provide a unique interface between basic and clinical science that strengthens its major goal of determining and understanding the molecular mechanisms of chronic lung disease. This incorporates a focus on three Research Areas:
Spot on Science
all-
13.04.2022 New Basal Cell Marker as target in Idiopathic Pulmonary Fibrosis
-
30.03.2022 Targeting prostanoid receptors offers therapeutic potential in COPD
-
22.03.2022 Pregnancy and Covid-19: Reduced lung volume in the unborn
-
14.03.2022 Epigenetic regulator promotes immunopathogenesis in COPD
-
03.03.2022 New approach against COVID-19: Targeted siRNA molecules destroy virus RNA
-
24.02.2022 Mapping the Pediatric Health: 340.000 € Grant for LHI scientists Hilgendorff/Schiller
We protect your privacy by not directly incorporating third-party content unless you have expressly consented to its display through our cookie layer. In this special case it concerns the embedment of twitter including their data policy. If you agree now, this will indicate that content of twitter and the transfer of data to twitter beginns. The legal basis for processing the data is if the user has given his consent according to Art. 6 Para. 1 S. 1 lit. a DSGVO.
